Zebra Pharmaceuticals Inc Columbia, SC - 29201

Zebra Pharmaceuticals Inc is categorized under Drugs, Proprietaries, and Sundries in Columbia, SC and active since 2007.

Zebra Pharmaceuticals Inc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Stephen M Tuel at the company’s single location by writing to 1225 Laurel St # 408, Columbia, South Carolina SC 29201 or by phoning (803) 699-1222. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Zebra Pharmaceuticals Inc
Contact Person: Stephen M Tuel
Address: 1225 Laurel St # 408, Columbia, South Carolina 29201
Phone Number: (803) 699-1222
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drugs, Proprietaries, and Sundries
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Zebra Pharmaceuticals Inc was started in 2007 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Stephen M Tuel for inquiries that concern Zebra Pharmaceuticals Inc by calling the company number (803) 699-1222, as your correspondence is most welcome. Additionally, the physical location of the single location of Zebra Pharmaceuticals Inc can be found at the coordinates 34.00953,-81.03668 as well as the street address 1225 Laurel St # 408 in Columbia, South Carolina 29201.

For its online presence, you may visit Zebra Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.